Establishment Labs Holdings Inc. earnings per share and revenue
On Nov 05, 2025, ESTA reported earnings of -0.38 USD per share (EPS) for Q3 25, beating the estimate of -0.54 USD, resulting in a 29.69% surprise. Revenue reached 53.78 million, compared to an expected 53.05 million, with a 1.38% difference. The market reacted with a +22.49% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 11 analysts forecast an EPS of -0.22 USD, with revenue projected to reach 64.98 million USD, implying an decrease of -42.11% EPS, and increase of 20.82% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Danaher Corporation
Report Date
Jan 28, 2026 For Q4 25
Estimate
$2.17
Actual
$2.23
Surprise
+2.56%
HCA Healthcare, Inc.
Report Date
Jan 27, 2026 For Q4 25
Estimate
$7.53
Actual
$8.14
Surprise
+8.05%
Elevance Health, Inc.
Report Date
Jan 28, 2026 For Q4 25
Estimate
$3.12
Actual
$3.33
Surprise
+6.46%
FAQ
What were Establishment Labs Holdings Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Establishment Labs Holdings Inc. reported EPS of -$0.38, beating estimates by 29.69%, and revenue of $53.78M, 1.38% above expectations.
How did the market react to Establishment Labs Holdings Inc.'s Q3 2025 earnings?
The stock price moved up 22.49%, changed from $49.40 before the earnings release to $60.51 the day after.
When is Establishment Labs Holdings Inc. expected to report next?
The next earning report is scheduled for Feb 24, 2026.
What are the forecasts for Establishment Labs Holdings Inc.'s next earnings report?
Based on 11
analysts, Establishment Labs Holdings Inc. is expected to report EPS of -$0.22 and revenue of $64.98M for Q4 2025.